ISSN: 2212-697X

Journal Home

Journal Guideline

Clinical Cancer Drugs Q1 Unclaimed

Bentham Science Publishers United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Cancer Drugs is a journal indexed in SJR in Oncology and Cancer Research with an H index of 4. It has an SJR impact factor of 1,287 and it has a best quartile of Q1. It has an SJR impact factor of 1,287.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1) Cancer Research (Q2) Oncology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,287

SJR Impact factor

4

H Index

0

Total Docs (Last Year)

1

Total Docs (3 years)

0

Total Refs

3

Total Cites (3 years)

1

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Cancer Q1
Journal of Thoracic Oncology Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals

Clinical Cancer Drugs Q1 Unclaimed

- €

NPD

- €

Metrics

1,287

4

0

1

0

3

1

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

FAQS

What is the impact factor of Clinical Cancer Drugs?